Nakase, Hiroshi http://orcid.org/0000-0003-2848-6586
Hayashi, Yuki
Hirayama, Daisuke
Matsumoto, Takayuki
Matsuura, Minoru
Iijima, Hideki
Matsuoka, Katsuyoshi
Ohmiya, Naoki
Ishihara, Shunji
Hirai, Fumihito
Abukawa, Daiki
Hisamatsu, Tadakazu
Sasaki, Makoto
Iizuka, Masahiro
Fujiya, Mikihiro
Matsumoto, Takayuki
Kinjo, Fukunori
Nakamura, Shiro
Kamata, Noriko
Iijima, Hideki
Etani, Yuri
Ueno, Fumiaki
Hiraoka, Sakiko
Kondo, Takeo
Kagaya, Takashi
Naganuma, Makoto
Kobayashi, Kiyonori
Kobayashi, Taku
Yamamoto, Shuji
Naito, Yuji
Hisamatsu, Tadakazu
Furuta, Yoki
Mitsuyama, Keichi
Hashimoto, Yu
Arai, Katsuhiro
Kato, Shingo
Iwama, Itaru
Esaki, Motohiro
Tanaka, Hiroki
Nakase, Hiroshi
Motoya, Satoshi
Maemoto, Atsuo
Ashida, Tomofumi
Nishimata, Nobuaki
Andoh, Akira
Yamamoto, Hironori
Ishihara, Shunji
Shimizu, Toshiaki
Maeda, Yasuharu
Kinoshita, Kenji
Fukuda, Katuyuki
Kato, Jun
Takeuchi, Ken
Nagahori, Masakazu
Fukuzawa, Masakatsu
Saruta, Masayuki
Itabashi, Michio
Shinozaki, Masaru
Ishihara, Soichiro
Yoshimura, Naoki
Matsuoka, Katsuyoshi
Kakuta, Yoichi
Takahashi, Kenichi
Sakemi, Ryosuke
Nanjo, Sohachi
Yoshikawa, Shusaku
Ozeki, Keiji
Fuchigami, Ayako
Katsurada, Takehiko
Watanabe, Kenji
Sakuraba, Hirotake
Hirai, Fumihito
Hisabe, Takashi
Ohmiya, Naoki
Hokari, Ryota
Nakai, Katsuhiko
Abukawa, Daiki
Yamamoto, Shojiro
Koganei, Kazutaka
Kunisaki, Reiko
Hokama, Akira
,
Funding for this research was provided by:
Ministry of Health, Labour and Welfare
Article History
Received: 17 December 2021
Accepted: 10 January 2022
First Online: 28 January 2022
Declarations
:
: Dr. Hiroshi Nakase (HN) reports receiving personal fees from Abbvie Inc., Kissei Pharmaceutical Co., Ltd., KYORIN Pharmaceutical Co., Ltd, Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceutical K.K, Takeda Pharmaceutical Co., Ltd., Pfizer Japan Inc., Celgene K.K., EA Pharma Co., Ltd., Zeria Pharmaceutical CO., Ltd., Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., D Daiichi Sankyo Co., Ltd., JIMRO Co., Ltd., as well as grants for commissioned/joint research from Hoya Group Pentax Medical, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company. Dr Yuki Hayashi (YH) and Dr. Daisuke Hirayama (DH) report no receipt of personal fees from any pharmaceutical companies. Dr. Takayuki Matsumoto (TM) reports receipt of personal fees from Abbvie Inc., Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K, Takeda Pharmaceutical Co., Ltd., EA Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and JIMRO Co., Ltd. Dr. Minoru Matsuura (MM) reports receipt of personal fees from AbbVie GK, Mitsubishi Tanabe Pharma Corporation, Nippon Kayaku Co., Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co. Ltd., Kyorin Pharmaceutical Co., Ltd., and Mochida Pharmaceutical Co., Ltd. Dr. Hideki Iijima (HI) report personal fees from AbbVie Inc, Janssen Pharmaceutical K.K., EA Pharma Co., Ltd., Eisai Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Ltd., Mochida Pharmaceutical Co. Ltd., and research grants from AbbVie Inc., Nippon Kayaku Co., Ltd, Daiichi Sankyo Company, Ltd. Dr. Katsuyoshi Matsuoka (KM) reports personal fees from AbbVie Inc, Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Ltd., Janssen Pharmaceutical K.K., Takeda Pharmaceutical Co., Ltd., Pfizer Lnc., EA Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., and commercial research funding from Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd, AbbVie GK, Nippon Kayaku Co., Ltd., EA pharma Co., Ltd. Dr. Naoki Ohmiya (NO) reports receiving grants for commissioned/joint research from Nippon Kayaku Co., Ltd. EA Pharma Co., Ltd., EA Pharma Co., Ltd. Dr. Shunji Ishihara (SI) reports receipt of personal fees from Takeda Pharmaceutical Co. Ltd and receiving grants for commissioned/joint research from Takeda Pharmaceutical Co. Ltd, Nippon Kayaku Co., Ltd., Astellas Pharma Inc., EA Pharma Co., Ltd., Zeria Pharmaceutical CO., Ltd., Daiichi Sankyo Company, Ltd., and JIMRO Co., Ltd. Dr. Fumihito Hirai (FH) reports receipt of personal fees from AbbVie GK, EA pharma Co., Ltd., Janssen Pharmaceutical K.K., Mochida Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co. Ltd. Dr. Daiki Abukawa reports no receipt of personal fees from any pharmaceutical companies. Dr. Tadakazu Hisamatsu (TH) receipt of personal fees from EA pharma Co. Ltd., AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd., JIMRO Co., Ltd., Mochida Pharmaceutical Co., Ltd., Nichi-lko Pharmaceutical Co., Ltd., and commercial research funding from EA pharma Co., Ltd., AbbVie GK, Daiichi-Sankyo Co., Ltd., Takeda Pharmaceutical Co. Ltd., Pfizer Inc., Mochida Pharmaceutical Co., Ltd, Nippon Kayaku Co., Ltd., Kyorin Pharmaceutical Co., Ltd., JIMRO Co.,Ltd., Mochida Pharmaceutical Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.